Navigation Links
Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
Date:12/1/2011

fter, and follow any dose adjustments. - Sudden deaths have been reported in patients receiving nilotinib. Do not administer TASIGNA to patients with hypokalemia, hypomagnesemia, or long QT syndrome. - Avoid use of concomitant drugs known to prolong the QT interval and strong CYP3A4 inhibitors.- Patients should avoid food 2 hours before and 1 hour after taking dose.
  • Treatment with TASIGNA can cause Grade 3/4 thrombocytopenia, neutropenia, and anemia. Complete blood counts should be performed every 2 weeks for the first 2 months and then monthly thereafter.
  • Caution is recommended in patients with a history of pancreatitis.
  • The use of TASIGNA may result in elevations in bilirubin, AST/ALT, and alkaline phosphatase.
  • TASIGNA can cause hypophosphatemia, hypokalemia, hyperkalemia, hypocalcemia, and hyponatremia (see Boxed WARNING).
  • The concomitant use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (including, but not limited to, amiodarone, disopyramide, procainamide, quinidine, and sotalol) and other drugs that may prolong the QT interval (including, but not limited to, chloroquine, clarithromycin, haloperidol, methadone, moxifloxacin, and pimozide) should be avoided. Grapefruit products should also be avoided. 
  • The concomitant use of strong CYP3A4 inducers should be avoided (including, but not limited to, dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, and St. John's wort).
  • TASIGNA must not be taken with food.
  • TASIGNA exposure is increased in patients with impaired hepatic function.
  • Cases of tumor lysis syndrome have been reported in TASIGNA treated patients with resistant or intolerant CML. Due to potential for tumor lysis syndrome, maintain adequate hydration and correct uric acid levels prior to initiating therapy with TASIGNA.
  • The exposure of TASIGNA is reduced in patients with total gastrectomy.
  • Since the capsules contain lactose, TASIGNA is not recommended for p
    '/>"/>

  • SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related biology technology :

    1. Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
    2. Genentech and Novartis Remain Image Leaders in Oncology and Hematology
    3. FDA Advisory Committee Recommends US Approval of Novartis Once-daily Bronchodilator QAB149 for COPD
    4. Novartis Drug Afinitor® Extends Progression-Free Survival in Patients With Advanced Pancreatic NET, Study Published in NEJM Shows
    5. With the Recent Launch of Novartiss Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch
    6. VIDEO from Novartis Available on thenewsmarket.com: Novartis Presents Data about Tasigna in Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
    7. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
    8. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
    9. Novartis Class Awarded $250 Million in Punitive Damages
    10. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
    11. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, ... diverse selection of entrepreneurs from across the United States to talk about their experiences ... honored to be chosen to be among the attendees. , One of the day’s ...
    (Date:8/4/2015)... Aug. 4, 2015   California Cryobank Stem Cell ... of LifeLine Cryogenics, an east coast cord blood and ... York tristate area. LifeLine clients will maintain ... contracts will be honored. Since 1991, LifeLine ... storage of sperm, eggs, embryos, and cord blood stem ...
    (Date:8/4/2015)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... today announced that it will release its unaudited financial ... after market close on Wednesday, August 12, 2015. The Company ... 2015, at 8:00 a.m. EDT (Thursday, August 13, 2015 ... Company,s financial results and provide an update on recent ...
    (Date:8/3/2015)... , Aug. 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... Call for the second quarter 2015 on Monday, August ... Helen Torley , president and chief executive officer, ... Halozyme will release financial results for the second quarter ... through the "Investors" section of Halozyme,s corporate website and ...
    Breaking Biology Technology:White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2FamilyCord Announces Acquisition of LifeLine Cryogenics 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2
    ... Isolation from E. coli Using the Eppendorf<sup , ... Plasmid Mini , Kit , , ... Joel Lopez, Melissa Higgins, Chere Griffin and Vince Prezioso, PhD , ... Introduction , Isolation and purification of plasmid DNA from bacteria ...
    ... or pathogens , Gabriela M. Tobal ,Stratagene ... Stratagene is introducing PCR primer sets ... these primers have been published previously,and are well ... use PCR technology to identify the presence of ...
    ... New PathDetect reporting system for ... Matthew Hsu Mary Buchanan Chao-Feng Zheng ... plasmid,the pNFAT-Luc reporter plasmid, is designed for studying ... (NFAT) transcription factors. These,interesting proteins, which play an ...
    Cached Biology Technology:Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 2Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 3Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 4New PCR Primers for Human Diseases 2New PCR Primers for Human Diseases 3New PCR Primers for Human Diseases 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 2Cis-Reporting System Monitors Intracellular Calcium Mobilization 3Cis-Reporting System Monitors Intracellular Calcium Mobilization 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 5
    (Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
    (Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
    (Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
    Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
    ... An international team of scientists has discovered striking similarities between ... a computer chip. The finding is reported in the journal ... compared to computers, but apart from the trivial fact that ... a physical space, it has been unclear whether this is ...
    ... AVIV, Israel , April 22, 2010 ... has co-authored a paper that brings together a myriad of ... kinetics. "Geometry-Controlled Kinetics," published in Nature Chemistry on April ... of a particular medium affects the motion of molecules or ...
    ... range of techniques for establishing crops in the previous ... surface. The principal benefits of conservation tillage are improved ... benefits can include reduced fuel consumption, planting and harvesting ... published in HortScience finds promise in a ...
    Cached Biology News:Brains, worms and computer chips have striking similarities 2Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 2Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry 3Cover crop mulches tested for no-till organic onions 2
    Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
    ... The tubing prep station, 100-120 V, is ... with DNA-coated gold particles to create the source ... helium discharge with the Helios gene gun. The ... O-rings, tubing prep unit, 12 foot Nalgene nitrogen ...
    Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
    The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
    Biology Products: